CME Information

PIM A 2C tag

ACCREDITED CONTINUING EDUCATION 

JAP LOGO ICE

In support of improving patient care, this activity has been planned and implemented by University of Nebraska Medical Center Bio Ascend. University of Nebraska Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

PHYSICIANS
The University of Nebraska Medical Center designates this live activity for a
maximum of 7.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

DISCLOSURE
As a jointly accredited provider, the University of Nebraska Medical Center (UNMC) ensures accuracy, balance, objectivity, independence, and scientific rigor in its educational activities and is committed to protecting learners from promotion, marketing, and commercial bias. All faculty, planners, and others in a positionto control continuing education content participating in an accredited continuing education activity are required to disclose all financial relationships with ineligible companies. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. The accredited provider is responsible for mitigating all relevant financial relationships in accredited continuing education. Disclosure of these commitments and/or relationships is included in these activity materials so that participants may formulate their own judgments in interpreting its content and evaluating its recommendations.

This activity may include presentations in which faculty may discuss off-label and/or investigational use of pharmaceuticals or instruments not yet FDA-approved. Participants should note that the use of products outside currently FDA-approved labeling should be considered experimental and are advised to consult current prescribing information for FDA-approved indications. All materials are included with the permission of the faculty. The opinions expressed are those of the faculty and are not to be construed as those of UNMC.

DISCLOSURES
The accredited provider has mitigated and is disclosing identified relevant
financial relationships for the following faculty, planners, and others in
control of content prior to assuming their roles:

Faculty
Hala Borno, MD
Co-Founder/CEO: Trial Library, Inc.

Julie Brahmer, MD, Msc
Grant/Research Support: AstraZeneca, BMS
Consultant: Amgen, AstraZeneca, BMS, Genentech/Roche, Eli Lilly, GlaxoSmithKline,
Merck, Sanofi, Regeneron, Janssen, Johnson & Johnson
Data and Safety Monitoring Board/Committees: Janssen

Robert Chen, MD
Employer: AstraZeneca

Nazli Dizman, MD
Consultant: Vivreon Bioscience Inc.

Narjust Florez, MD
Advisory Board Consultant: AstraZeneca, DSI, Pfizer, Janssen, Merck, Regeneron

Kathryn Hudson, MD
Ad Board: Daiichi Sankyo, Gilead

Reshma Mahtani, DO
Advisor/Consultant: Agendia, Amgen, AstraZeneca, Biotheranostics, Daiichi, Eisai,
Genentech, Immunomedics, Lilly, Novartis, Pfizer, Puma, Sanofi, SeaGen
Research Funding: Genentech, Gilead

Autumn McRee, MD
Employer: Janssen Research and Development

Neha Mehta-Shah, MD, MSCI
Advisory Board Consultant: AstraZeneca, C4 Therapeutics
Grant/Institutional Research Funding: AstraZeneca, Bristol-Myers Squibb, C4
Therapeutics, Corvus Pharmaceuticals, Daiichi Sankyo

Theresa Ramirez Montagut, MD, PhD
Employer: Regeneron Pharmaceuticals

Sumanta Pal, MD, FASCO
Consultant: CRISPR Therapeutics, Ipsen

Ana Sandoval Leon, MD
Advisory Board: Merck, Sanofi, AstraZeneca, Gilead, Sermonix

Nina Shah, MD
Employment/stock ownership: AstraZeneca
Research funding: BMS, Janssen, Bluebird Bio, Sutro Biopharma, Teneobio, Poseida,
Nektar, Precision Biosciences
Consultant: GSK, Amgen, Indapta Therapeutics, Sanofi, CareDx, Kite, Karyopharm,
Oncopeptides, CSL Behring, Allogene, AbbVie

Rachna Shroff, MD, MS, FASCO
Research Funding: IMV Inc., LOXO, Merck, Novocure, NUCANA, Bristol-Myers Squibb,
Pieris, QED Therapeutics, Seagen, Taiho, Bayer
Advisory Board Member: Incyte, Merck, QED Therapeutics, Server, Zymeworks
Biopharm, Astellas, Duo, AstraZeneca, Boehringer Ingelheim Pharm, Clovis,
Genentech, Natera
Consultant: SYROS, Hookipa Pharma, AbbVie

Margaret Tempero, MD
DSMC: Astellas Pharma Global Development Inc.
Advisory Board: BeiGene, Biotech Research, Boehringer Ingelheim, Merus, BMS
Consultant: AstraZeneca, B2ACT Therapeutics Genex, BioSapiens, Blueprint,
ElmediX, Debiopharm, Geistlich Pharma, Global Bio Access Fund, IPSEN Biopharma,
Inc., Mirati Therapeutics Inc., Novartis Pharmaceuticals, B2ACT Therapeutics Genex,
ONCOLYTICS, PEPTOMYC, S.L.
Scientific Advisor: Exact Sciences
SAB: Global Bio Access Fund

Eleonora Teplinsky, MD
Medical Advisor, Honoraria: Sermo
Honoraria: Achieve CE, Bonum CE, Integrity CE, TotalHealth Conference
Consulting: Eisai, AstraZeneca
Medical Advisor: FloHealth

Mazie Tsang, MD, MAS, MS
Stock ownership: Poseida Therapeutics, AVEO
Consultant: Novartis

Ana Velazquez Manana, MD, MSc
Consultant: AstraZeneca, Merus, N.V.

Julie Vose, MD, MBA
Consultant: Genmab

Shannon Westin, MD, MPH, FACOG
Grants to Institution: AstraZeneca, AvengeBio, Bayer, Bio-Path, Clovis Oncology,
GSK, Jazz Pharmaceuticals, Mereo, Novartis, Nuvectis, Roche/Genentech, Zentalis
Consultant: AstraZeneca, Caris, Clovis Oncology, Eisai, EQRX, Gilead, GSK,
Immunocore, ImmunoGen, Lilly, Merck, Mereo, Mersana, NGM Bio, Nuvectis,
Roche/Genentech, SeaGen, Verastem, Vincerx, Zentalis, ZielBio

Karen Winkfield, MD, PhD
Consultant: Astellas, Merck, Bristol-Myers Squibb
 
Antoinette Wozniak, MD, FACP, FASCO
Consultant: AstraZeneca
Speaker: OncLive, Epic

The following faculty members have nothing to disclose:

Carolina Bernabe, MD
Brenda Ernst, MD
Julie Gralow, MD, FACP, FASCO
Beth Hellerstedt, MD
Ariela Marshall, MD
Barbara McAneny, MD
Debra Patt, MD, PhD, MBA
Sarah Temkin, MD
Catherine Tinsley, PhD

Planning Committee

The following planning committee members have nothing to disclose:
UNMC: Brenda Ram, CMP, CHCP
Bio Ascend: Patti Bunyasaranand, MS; Dru Dace, PhD; Kraig Steubing
 

How to Claim Credit

  1. CLICK HERE to complete the program evaluation
  2. After submitting the evaluation, your web browser will be redirected to a CME Request Form
  3. Complete the CME Request Form in its entirety
  4. Your CME certificate will be emailed to you within 30 days 

For questions regarding CME credit for this activity, please contact BRAM@UNMC.EDU.